INTERNATIONAL PATENT: BEIJING HORICIN BIOTECHNOLOGY CO., LTD., 北京华睿鼎信科技有限公司 FILES APPLICATION FOR "NUCLEIC ACID APTAMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF"

Posted On: 2025-05-05

GENEVA, May 5 -- BEIJING HORICIN BIOTECHNOLOGY CO., LTD. (Unit 3, Building 2, No.2, Jinghaisi Road, Beijing Economic-Technological Development Area,Daxing District, Beijing 100023), 北京华睿鼎信科技有限公司 (中国北京市大兴区北京经济技术开发区经海四路2号2号楼3单元) filed a patent application (PCT/CN2024/126452) for "NUCLEIC ACID APTAMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION, AND USE THEREOF" on Oct 22, 2024. With publication no. WO/2025/087235, the details related to the patent application was published on May 01...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BEIJING HORICIN BIOTECHNOLOGY CO., LTD., 北京华睿鼎信科技有限公司 FILES APPLICATION FOR "NUCLEIC ACID APTAMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF"